Clinical Trials Browser

Phase 3 × OTHER × ruxolitinib × Clear all

NCT04116502 2024-11-18

MITHRIDATE

Phase 3 Recruiting

Polycythemia Vera

NCT05663827 2024-03-05

Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease

Phase 3 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma